Trupanion (NASDAQ:TRUP) was downgraded by Zacks Investment Research from a “strong-buy” rating to a “hold” rating in a research note issued to investors on Thursday.

According to Zacks, “Trupanion, Inc. operates as a direct-to-consumer monthly subscription service provider of a medical insurance plan for cats and dogs. It operates primarily in Canada, Puerto Rico, and the United States. The Company serves pet owners and veterinarians. Trupanion, Inc. is headquartered in Seattle, Washington. “

A number of other brokerages have also recently commented on TRUP. Craig Hallum began coverage on shares of Trupanion in a research note on Thursday, July 19th. They issued a “buy” rating and a $55.00 price objective on the stock. BidaskClub cut shares of Trupanion from a “strong-buy” rating to a “buy” rating in a research note on Saturday, July 28th. Cowen increased their price objective on shares of Trupanion from $41.00 to $47.00 and gave the company a “positive” rating in a research note on Friday, August 3rd. Royal Bank of Canada increased their price objective on shares of Trupanion to $44.00 and gave the company an “outperform” rating in a research note on Friday, August 3rd. Finally, Lake Street Capital reissued a “buy” rating and issued a $46.00 price objective (up from $41.00) on shares of Trupanion in a research note on Friday, August 3rd. One research analyst has rated the stock with a sell rating, one has assigned a hold rating and ten have assigned a buy rating to the company. The stock has an average rating of “Buy” and a consensus price target of $45.22.

Shares of NASDAQ TRUP opened at $29.63 on Thursday. The stock has a market capitalization of $1.17 billion, a P/E ratio of -423.29 and a beta of 0.60. Trupanion has a 52 week low of $25.50 and a 52 week high of $46.70. The company has a debt-to-equity ratio of 0.16, a quick ratio of 3.04 and a current ratio of 3.04.

Trupanion (NASDAQ:TRUP) last issued its quarterly earnings data on Thursday, August 2nd. The financial services provider reported ($0.01) EPS for the quarter, beating the Zacks’ consensus estimate of ($0.05) by $0.04. The firm had revenue of $73.39 million for the quarter, compared to analysts’ expectations of $72.70 million. Trupanion had a negative net margin of 0.84% and a negative return on equity of 4.43%. The firm’s revenue was up 25.9% on a year-over-year basis. During the same period in the prior year, the company earned ($0.02) EPS. As a group, equities research analysts expect that Trupanion will post -0.08 earnings per share for the current year.

In other Trupanion news, CEO Darryl Rawlings sold 4,000 shares of the firm’s stock in a transaction dated Wednesday, August 8th. The shares were sold at an average price of $38.18, for a total transaction of $152,720.00. Following the sale, the chief executive officer now directly owns 1,293,989 shares of the company’s stock, valued at approximately $49,404,500.02. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Murray B. Low sold 3,000 shares of the firm’s stock in a transaction dated Friday, August 10th. The stock was sold at an average price of $38.12, for a total transaction of $114,360.00. Following the sale, the director now directly owns 189,782 shares in the company, valued at $7,234,489.84. The disclosure for this sale can be found here. Insiders have sold a total of 23,450 shares of company stock worth $901,839 over the last ninety days. 20.70% of the stock is owned by corporate insiders.

Several institutional investors have recently added to or reduced their stakes in TRUP. Riverbridge Partners LLC acquired a new stake in shares of Trupanion during the 2nd quarter worth about $20,130,000. Morgan Stanley boosted its stake in shares of Trupanion by 41.5% during the 2nd quarter. Morgan Stanley now owns 1,157,405 shares of the financial services provider’s stock worth $44,675,000 after purchasing an additional 339,550 shares during the last quarter. BlackRock Inc. boosted its stake in shares of Trupanion by 21.3% during the 2nd quarter. BlackRock Inc. now owns 1,619,838 shares of the financial services provider’s stock worth $62,525,000 after purchasing an additional 284,030 shares during the last quarter. Columbus Circle Investors acquired a new stake in shares of Trupanion during the 2nd quarter worth about $8,776,000. Finally, Public Employees Retirement Association of Colorado acquired a new stake in shares of Trupanion during the 2nd quarter worth about $7,141,000. 93.92% of the stock is currently owned by institutional investors.

Trupanion Company Profile

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on monthly subscription basis in the United States, Canada, and Puerto Rico. The company operates through Subscription Business and Other Business segments. It serves pet owners and veterinarians through third-party referrals and online member acquisition channels.

Further Reading: Does the discount rate affect the economy?

Get a free copy of the Zacks research report on Trupanion (TRUP)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Analyst Recommendations for Trupanion (NASDAQ:TRUP)

Receive News & Ratings for Trupanion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion and related companies with MarketBeat.com's FREE daily email newsletter.